No Data
No Data
The Trader: Healthcare Stocks Are Showing Life Beyond Lilly and GLP-1s -- Barron's
JPMorgan Chase, Goldman Sachs Share Gains Lead Dow's 430-Point Rally
Novo Nordisk, Eli Lilly Could Face Downward Pressure Despite Market Dominance From Potentially 16 New Obesity Drugs: See The Names
Morgan Stanley Adjusts Price Target on Amgen to $319 From $316
Morgan Stanley Keeps Their Hold Rating on Amgen (AMGN)
Amgen (AMGN) Dips More Than Broader Market: What You Should Know
104476495 : h
章允量 :
affable Blobfish_403 : The economic recession is hard to conceal, but the economic data before the election shouldn't look too bad, right?! Data is often revised afterwards.
103677010 : noted
Ghost2737 affable Blobfish_403 : Data is fake
View more comments...